Cambridge Investment Research Advisors Inc. purchased a new position in Option Care Health, Inc. (NASDAQ:OPCH – Get Rating) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 8,662 shares of the company's stock, valued at approximately $273,000.
Several other hedge funds have also made changes to their positions in the stock. American Century Companies Inc. bought a new stake in Option Care Health during the 1st quarter valued at $907,000. Healthcare of Ontario Pension Plan Trust Fund bought a new stake in Option Care Health during the 1st quarter valued at $500,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in Option Care Health by 10.5% during the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 50,760 shares of the company's stock valued at $1,450,000 after acquiring an additional 4,840 shares in the last quarter. Great West Life Assurance Co. Can raised its stake in Option Care Health by 8.2% during the 1st quarter. Great West Life Assurance Co. Can now owns 74,363 shares of the company's stock valued at $2,181,000 after acquiring an additional 5,637 shares in the last quarter. Finally, Yousif Capital Management LLC raised its stake in Option Care Health by 1.8% during the 1st quarter. Yousif Capital Management LLC now owns 77,343 shares of the company's stock valued at $2,209,000 after acquiring an additional 1,349 shares in the last quarter. Institutional investors own 97.63% of the company's stock.
Get Option Care Health alerts:Option Care Health Stock Down 0.5 %
Shares of OPCH stock opened at $28.94 on Friday. Option Care Health, Inc. has a 1 year low of $21.32 and a 1 year high of $35.87. The stock has a market cap of $5.26 billion, a PE ratio of 29.53, a price-to-earnings-growth ratio of 2.29 and a beta of 1.17. The business's fifty day moving average is $29.70 and its 200-day moving average is $31.25. The company has a debt-to-equity ratio of 0.79, a quick ratio of 1.22 and a current ratio of 1.62.
Option Care Health (NASDAQ:OPCH – Get Rating) last issued its quarterly earnings results on Thursday, October 27th. The company reported $0.21 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.21. Option Care Health had a return on equity of 11.80% and a net margin of 4.64%. The company had revenue of $1.02 billion for the quarter, compared to analysts' expectations of $994.38 million. Equities analysts expect that Option Care Health, Inc. will post 0.79 earnings per share for the current fiscal year.Wall Street Analysts Forecast Growth
Separately, Barrington Research lifted their target price on Option Care Health from $37.00 to $38.00 and gave the company an "outperform" rating in a research note on Friday, October 28th.
Option Care Health Company Profile
(Get Rating)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Recommended Stories
- Get a free copy of the StockNews.com research report on Option Care Health (OPCH)
- MarketBeat: Week in Review 01/09-01/13
- JPMorgan Chase Falls As Banks Brace For Recession
- Why is the Bed Bath & Beyond Stock Price up 261%?
- Roku Stock Price is Trending, Here's Why
- Carvana Stock Rally, Here's What You Need to Know
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.